Visceral Leishmaniasis as a cause of fever of unknown origin: a unique disease pattern shown on [18F]-FDG PET/CT

Česká verze

Authors: G. Horňák ¹; P. Turcsányi ²; V. Látal ²; K. Aiglová ³; F. Stejskal ⁴; T. Tichý ⁵; I. Zicklerová ⁶; L. Quinn ¹
Authors place of work: Klinika nukleární medicíny LF UP a FN Olomouc ¹; Hemato-onkologická LF UP a FN Olomouc ²; II. interní klinika – gastroenterologická a geriatrická LF UP a FN Olomouc ³; Klinika infekčních nemocí 1., 2. a 3. LF UK a FN Bulovka, Praha ⁴; Ústav klinické a molekulární patologie LF UP a FN Olomouc ⁵; Národní referenční laboratoř pro diagnostiku tropických parazitárních infekcí, FN Bulovka, Praha ⁶
Published in the journal: Gastroent Hepatol 2025; 79(2): 115-119
Category: Hepatologie
doi: https://doi.org/10.48095/ccgh2025115

Summary

This case report describes a 69-year-old man with visceral Leishmaniasis. The progressively worsening clinical condition of the patient, combined with nonspecific imaging findings and laboratory results, led to diagnostic difficulties in identifying this rarely encountered infectious disease in the Czech Republic. The paper is supplemented with an overview of recent epidemiological data, diagnostic procedures, and treatment of Leishmaniasis.

Keywords:

Leishmaniasis – PET/ CT – fever of unknown origin – hepatopathy

Zdroje

1. Votrubová J. Klinické PET a PET/CT. Praha: Galén 2009.

2. Kamínek M. Nukleární medicína. Olomouc: Univerzita Palackého v Olomouci 2024.

3. Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet 2018; 392 (10151): 951–970. doi: 10.1016/S0140-6736 (18) 31204-2.

4. Handler MZ, Patel PA, Kapila R et al. Cutaneous and mucocutaneous leishmaniasis: clinical perspectives. J Am Acad Dermatol 2015; 73 (6): 897–908. doi: 10.1016/j.jaad.2014.08.051.

5. McGwire BS, Satoskar AR. Leishmaniasis: clinical syndromes and treatment. QJM 2014; 107 (1): 7–14. doi: 10.1093/qjmed/hct116.

6. van Griensven J, Dorlo TP, Diro E et al. The status of combination therapy for visceral leishmaniasis: an updated review. Lancet Infect Dis 2024; 24 (1): e36–e46. doi: 10.1016/S1473-3099 (23) 00353-5.

7. Cunha BA, Lortholary O, Cunha CB. Fever of unknown origin: a clinical approach. Am J Med 2015; 128 (10): 1138.e1–1138.e15. doi: 10.1016/ j.amjmed.2015.06.001.

8. Krivanová A, Adam Z, Mayer J et al. Fever of unknown origin –⁠ etiology and diagnostic algorithm. Vnitr Lek 2007; 53 (2): 169–178.

9. Minamimoto R. Optimal use of the FDG-PET/CT in the diagnostic process of fever of unknown origin (FUO): a comprehensive review. Jpn J Radiol 2022; 40 (11): 1121–1137. doi: 10.1007/s11604-022-01306-w.

10. Zanoni L, Varani S, Attard L et al. 18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy. Ann Nucl Med 2019; 33 (9): 716–723. doi: 10.1007/s12149-019-01381-6.

11. Boellaard R, Delgado-Bolton R, Oyen WJ et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 2015; 42 (2): 328–354. doi: 10.1007/s00259-014-2961-x.

12. Jeong YJ, Sohn MH, Lim ST et al. „Hot liver“ on 18F-FDG PET/CT imaging in a patient with hepatosplenic tuberculosis. Eur J Nucl Med Mol Imaging 2010; 37 (8): 1618–1619. doi: 10.1007/s00259-010-1477-2.

13. Wong SS, Yuen HY, Ahuja AT. Hepatic tuberculosis: a rare cause of fluorodeoxyglucose hepatic superscan with background suppression on positron emission tomography. Singapore Med J 2014; 55 (7): e101–e103. doi: 10.11622/smedj.2013237.

14. Vijayakumary B, Ramachandran C, Bharath VM et al. Hot liver on 18F-FDG PET/CT imaging-a quandary for oncoradiologists in South Asia. BJR Case Rep 2020; 6 (2): 20190097. doi: 10.1259/bjrcr.20190097.

15. Luk WH, Au-Yeung AW, Loke TK. Imaging patterns of liver uptakes on PET scan: pearls and pitfalls. Nucl Med Rev Cent East Eur 2013; 16 (2): 75–81. doi: 10.5603/NMR.2013.0039.